All In Biotech

Drug Trial Radar · NCT00233064

Study to Assess the Immune Reactivity of the Liquid and Lyophilized Formulations of Palivizumab (MEDI-493, Synagis)

A Phase IV, Randomized, Double-Blind Study to Assess the Immune Reactivity of the Liquid and Lyophilized Formulations of Palivizumab (MEDI-493, Synagis) in Children at High Risk for the Development of Serious RSV Disease

Last checked: Nov 20, 2026Latest source record: Jun 27, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 417 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

417

Actual

Start

Oct 2005

Primary completion

Oct 2007

Study completion Nov 2007

Sponsor

Lead sponsor
MedImmune LLCAstraZeneca (AZN)
Sponsor type
Industry
First posted
Oct 5, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, up to 24 months
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to measure the rate of anti-palivizumab antibodies (also referred to as immune reactivity or immunogenicity) in subjects receiving either the liquid or lyophilized formulation of palivizumab. This study will compare the number and percentage of subjects with anti-palivizumab antibodies receiving either the liquid or lyophilized formulation of palivizumab.

Conditions

  • Chronic Lung Disease

Interventions

  • Lyophilized PalivizumabBiological

    Patients will receive 15 mg/kg of lyophilized palivizumab administered intramuscularly every 30 days for a total of 5 injections.

  • Liquid PalivizumabBiological

    Patients will receive 15 mg/kg of liquid palivizumab administered intramuscularly every 30 days for a total of 5 injections.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number and Percentage of Participants With Immune ReactivityTime frame: Day 240-300 follow up

Locations

54 sites in 1 country. Site status is shown where the registry gives one.

  • Birmingham Pediatric Associates

    Birmingham, Alabama

  • Clinical Research Consultants

    Hoover, Alabama

  • The University of Alabama School of Medicine

    Tuscaloosa, Alabama

  • All for Kids Pediatric Clinic

    Little Rock, Arkansas

  • Family Medical Center

    Foothill Ranch, California

  • Edinger Medical Group

    Fountain Valley, California

  • Doctors Medical Group

    West Covina, California

  • Convenience Care

    West Covina, California

  • Norwich Pediatric Group, P.C.

    Norwich, Connecticut

  • The Allergy Center at Brookstone

    Columbus, Georgia

  • Physicians to Children and Adolescents

    Bardstown, Kentucky

  • Peak Medical Research LLC

    Owensboro, Kentucky

  • Boston University Medical Center

    Boston, Massachusetts

  • Pediatric Association of Fall River

    Fall River, Massachusetts

  • Woburn Pediatric Associates

    Woburn, Massachusetts

  • Michigan Institute of Medicine

    Livonia, Michigan

  • Meridian Clinical Research

    Omaha, Nebraska

  • St. Joseph's Childrens Hospital

    Paterson, New Jersey

  • Maimonides Pediatric Pulmonology

    Brooklyn, New York

  • North Carolina Children's & Adult's Clinical Research Foundation/Purcell Clinic

    Laurinburg, North Carolina

  • Capitol Pediatric And Adolescent Center

    Raleigh, North Carolina

  • North Carolina Children's and Adult's Clinical Research Foundation

    Sylva, North Carolina

  • Medcenter One/Q&R Clinic

    Bismarck, North Dakota

  • Dakota Clinic, Ltd. / Innvois Health

    Fargo, North Dakota

  • Trinity Medical Group-Health Center Medical Arts

    Minot, North Dakota

  • Dr. Shelly David Senders, M.D., Inc.

    Cleveland, Ohio

  • Northeast Cincinnati Pediatric Associates, Inc

    Mason, Ohio

  • Santiago Reyes, M.D.

    Oklahoma City, Oklahoma

  • Tri-State Pediatrics

    Beaver Falls, Pennsylvania

  • Greenville Medical Center

    Greenville, Pennsylvania

  • CCP - Armstrong Pediatrics

    Kittanning, Pennsylvania

  • Pediatric Alliance of Latrobe

    Latrobe, Pennsylvania

  • Temple Univ. Children's Medical Center

    Philadelphia, Pennsylvania

  • Pediatric Alliance, Southwestern

    Pittsburgh, Pennsylvania

  • South Hills Pediatrics

    Pittsburgh, Pennsylvania

  • Pediatric Alliance, Southwestern

    Pittsburgh, Pennsylvania

  • Primary Physician's Research, Inc.

    Pittsburgh, Pennsylvania

  • Laurel Pediatrics

    Uniontown, Pennsylvania

  • Brown Clinic P.L.L.P./Northridge Clinic

    Watertown, South Dakota

  • Jackson Clinic

    Jackson, Tennessee

Showing 40 of 54 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.